Eastman Chemical posts Q4 2025 results via 8-K
Eastman Chemical Company filed a current report to furnish its financial results for the fourth quarter of 2025.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Eastman Chemical Company filed a current report to furnish its financial results for the fourth quarter of 2025. The company states that it publicly released these results on January 29, 2026, and has attached the full earnings press release as an exhibit.
The earnings release is provided as Exhibit 99.01 and is incorporated by reference, but is designated as “furnished” rather than “filed” under securities law, which affects how it is treated for certain legal liabilities and future regulatory filings.
8-K Event Classification
2 items: 2.02, 9.01
2 items
Item 2.02
Results of Operations and Financial Condition
Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Eastman Chemical (EMN) disclose in this 8-K filing?
Eastman Chemical disclosed that it has released its financial results for the fourth quarter of 2025. The company furnished the full earnings press release as Exhibit 99.01 to the report, making the detailed financial information available through that attached document.
When did Eastman Chemical (EMN) release its Q4 2025 financial results?
Eastman Chemical released its fourth quarter 2025 financial results on January 29, 2026. The same date is referenced in the current report, which furnishes the full earnings press release as an exhibit for investors and regulators to review.
Where can investors find Eastman Chemical’s Q4 2025 results in the 8-K?
Investors can find Eastman Chemical’s fourth quarter 2025 financial results in Exhibit 99.01 to the report. The filing explains that the complete text of the company’s earnings press release is furnished as this exhibit and incorporated by reference.
Is Eastman Chemical’s Q4 2025 earnings release considered filed with the SEC?
The Q4 2025 earnings release is treated as furnished, not filed, with the SEC. Eastman Chemical notes that this information is not deemed filed for Section 18 liability or automatically incorporated into other securities law filings unless specifically referenced.
Which Eastman Chemical executive signed this 8-K for Q4 2025 results?
The report was signed on behalf of Eastman Chemical by Michelle R. Stewart. She is identified in the document as the company’s Vice President, Chief Accounting Officer, and Corporate Controller, acting as the authorized signatory for the filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
(Exact Name of Registrant as Specified in Its Charter)
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
| (Address of Principal Executive Offices) | (Zip Code) | |||||||
(423 ) 229-2000
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||||||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||||||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||||||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||||||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| EASTMAN CHEMICAL COMPANY - EMN | ||||||||
Item 2.02 Results of Operations and Financial Condition
On January 29, 2026, the registrant publicly released its financial results for fourth quarter 2025. The full text of the release is furnished as Exhibit 99.01 to this Current Report on Form 8-K, and is incorporated herein by reference. This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits:
(d) Exhibits
The following exhibits are furnished pursuant to Item 9.01:
99.01 Public release by Eastman on January 29, 2026 of fourth quarter 2025 financial results
104 Cover Page Interactive Data File
| EASTMAN CHEMICAL COMPANY - EMN | ||||||||
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Eastman Chemical Company | ||||||||
| By: | /s/ Michelle R. Stewart | |||||||
| Michelle R. Stewart | ||||||||
| Vice President, Chief Accounting Officer and Corporate Controller | ||||||||
Date: January 29, 2026 | ||||||||